Last reviewed · How we verify

NCT02544269

Hemodynamic Effect of Lumbosacral Plexus Blockade Versus Spinal Anesthesia

Terminated Phase 4 Last updated 5 May 2017
What this trial tests

Phase 4 trial testing Ropivacaine in Total Hip Replacement in 8 participants. Terminated before completion.

Timeline
1 June 2016
Primary endpoint
25 January 2017
25 January 2017

Quick facts

Lead sponsorUniversity of Aarhus
PhasePhase 4
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeother
Enrollment8
Start date1 June 2016
Primary completion25 January 2017
Estimated completion25 January 2017
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Aarhus

Who can join

50 and older, any sex, with Total Hip Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study evaluates the hemodynamic effect of lumbosacral plexus blockades versus spinal anesthesia for hip replacement. Half of participants will receive lumbosacral plexus blockade and the other half will receive continuous spinal anesthesia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults.
    Guay J, Johnson RL, Kopp S. · · 2017 · cited 35× · PMID 29087547 · DOI 10.1002/14651858.cd011608.pub2

Verify or expand the search:

Other trials of Ropivacaine

Trials testing the same drug.

Other recruiting trials for Total Hip Replacement

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02544269.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing